![Issue Cover](https://cdn.statically.io/img/oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/jid/Issue/229/Supplement_3/1/m_jid_229_suppl_3cover.jpeg?Expires=1724872354&Signature=oj369NrI8R8K~Ogo4BgZbNEBX0ShqAiodbhwjrgqsloiouIGEwOTpGnUTUkpcSXOxtnOfYM1db7XtcZG9KNSDM59srvV9JWj-EQZoauje1saeKoaFcHb-01y5q2mXd~22XBpEjqr3D985D~aOveE644xCtZlyZbaIkEKXaCoUz6miH1ONK~bHeHTqONT3kCuTj8~lfbYfPAghkHuJ0Ec81xxd8lIBlzYFxw3oxQeCdS98nKxas~ZVNQ3RxPCodYmqoynXnkec4HV49SXFKcHzr6A2jLjGIgI0aPffGbEA3CV6b7AqXXE-zqyW6fe2clyQ17~gsl9SCD0j3XO~WumAQ__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Volume 229, Issue Supplement_3
15 May 2024
Cover image
Cover image
![issue cover](https://cdn.statically.io/img/oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/jid/Issue/229/Supplement_3/1/jid_229_supplement_3coverfig.jpeg?Expires=1724872354&Signature=URywcNu-xhoZBybGfsYS1cALEOM23WQ7~Ll5FwFNRCCIRg-0XjStzLKtfhNodYvyaK2ehix9SsXARAy5bksDUDOuS5KtnB~xv9LUBIddnBYQ00WchcPgOLp94HoBNlk23TOs~iTD2GjbCXSuN3ksJoZMbSbNfGbzfXNkV2EgVdLSIIyKV-ymg7P95-aw76H9JYKusy0rxYpW-hG5xDa2IgtYv4A26mTVrPr64WSo2db0~411RR1208Pk3Fr-Tt-l8~u0FTpzhXDyEBu3BXdJN84ArESzDZxdjRDsNNQlPYeV6GCSudVYbSgKloKN8Y4RUSU1EbtH5vBxg89H0L6iQA__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
On the cover: An artist rendering of the hepatitis C virus (HCV). HCV belongs to the Hepacivirus genus of the Flaviviridae family. HCV virions consist of a lipid bilayer formed by envelope glycoproteins (E1 and E2); the envelope surrounds the nucleocapsid, which is composed of HCV core protein and contains the positive-strand RNA genome of approximately 9.6 kb. After exposure to HCV, the first viral marker detectable in blood 1–2 weeks after infection is HCV RNA; another viral marker, HCV core antigen (HCV cAg) is detectable 2–3 weeks after infection. Antibodies to HCV can be detected an average of 7–8 weeks after infection and persist for life. Antibodies to HCV indicate current or past-resolved infection, diagnosis of current HCV infection requires detection of a viral marker, HCV RNA or HCV cAg.
ISSN 0022-1899
EISSN 1537-6613
Issue navigation
Volume 229, Issue Supplement_3, 15 May 2024
Towards a Single-Step Diagnosis of Hepatitis C Virus Infection
Supplement Articles
Advancing Diagnosis of Current Hepatitis C Virus Infection: A Key to Hepatitis C Elimination in the United States
Saleem Kamili and Carolyn Wester
The Journal of Infectious Diseases, Volume 229, Issue Supplement_3, 15 May 2024, Pages S313–S315, https://doi.org/10.1093/infdis/jiae127
What Is Needed to Move Toward Single-Step Diagnosis of Current HCV Infection?
Jordan J Feld
The Journal of Infectious Diseases, Volume 229, Issue Supplement_3, 15 May 2024, Pages S316–S321, https://doi.org/10.1093/infdis/jiad453
Down-Classification of Hepatitis C Virus Diagnostics: Implications for Screening and Diagnosis
Norah Terrault
The Journal of Infectious Diseases, Volume 229, Issue Supplement_3, 15 May 2024, Pages S322–S327, https://doi.org/10.1093/infdis/jiad299
What Hepatitis C Virus (HCV) Diagnostic Tools Are Needed to Advance Diagnosis of Current HCV Infection in Outreach Settings and in a Nonclinical Setting?
Kimberly Page and Judith Feinberg
The Journal of Infectious Diseases, Volume 229, Issue Supplement_3, 15 May 2024, Pages S328–S333, https://doi.org/10.1093/infdis/jiad269
Lessons Learned From Global Hepatitis C Elimination Programs
Senad Handanagic and others
The Journal of Infectious Diseases, Volume 229, Issue Supplement_3, 15 May 2024, Pages S334–S341, https://doi.org/10.1093/infdis/jiad198
Molecular Point-of-Care Testing for Hepatitis C: Available Technologies, Pipeline, and Promising Future Directions
Elena Ivanova Reipold and others
The Journal of Infectious Diseases, Volume 229, Issue Supplement_3, 15 May 2024, Pages S342–S349, https://doi.org/10.1093/infdis/jiad463
Opportunities for Enhanced Prevention and Control of Hepatitis C Through Improved Screening and Testing Efforts
Emily J Cartwright and Priti R Patel
The Journal of Infectious Diseases, Volume 229, Issue Supplement_3, 15 May 2024, Pages S350–S356, https://doi.org/10.1093/infdis/jiad199
Maximizing Reflexive Hepatitis C Virus (HCV) RNA Testing of HCV Antibody-Reactive Samples Within United States Public Health Laboratories
Lauren N Johnson and others
The Journal of Infectious Diseases, Volume 229, Issue Supplement_3, 15 May 2024, Pages S357–S361, https://doi.org/10.1093/infdis/jiad191
Tools Needed to Support Same-Day Diagnosis and Treatment of Current Hepatitis C Virus Infection
Gregory P Fricker and others
The Journal of Infectious Diseases, Volume 229, Issue Supplement_3, 15 May 2024, Pages S362–S369, https://doi.org/10.1093/infdis/jiad177
Advertisement
Advertisement